Literature DB >> 17117749

Left atrial function in patients with a high C-reactive protein level and paroxysmal atrial fibrillation.

John Dernellis1, Maria Panaretou.   

Abstract

OBJECTIVE: We evaluated left atrial dimensions and function in high C-reactive protein (CRP) patients with paroxysmal atrial fibrillation.
BACKGROUND: In patients with increased plasma levels of CRP left atrial dysfunction may enhance the occurrence of arrhythmias.
METHODS: Two-dimensional and pulsed Doppler echocardiography, were performed in 20 consecutive patients with high CRP levels and paroxysmal atrial fibrillation (group CRf) and in 20 patients with high CRP levels without this arrhythmia (group CR). Twenty normal subjects (group N) were also investigated. Groups were matched for age and gender.
RESULTS: CRP was increased in the CRf (median = 1.03 mg/dl), CR (median = 0.84 mg/dl) and N groups (median = 0.23 mg/dl), (p < 0.001) for all comparisons. The CRf, CR and N groups had similar systolic and diastolic blood pressure, left ventricular mass index, left ventricular ejection fraction, isovolumic relaxation time and peak early and late transmitral Doppler flow velocities. Maximal left atrial volume was greater only in the CRf group (54.4 +/- 6.3 ml) compared with the N group (50.3 +/- 4.9 ml, p < 0.05). Left atrial volume preceding atrial contraction was similar in all groups, p=NS. Left atrial minimal volume decreased from 23.0 +/- 1.8 ml in the CRf group, to 19.8 +/- 1.8 ml in the CR group, p < 0.001 and to 18.1 +/- 2.1 ml in the N group, (p < 0.02). The passive emptying fraction of the CRf and CR groups was comparable to that of normal subjects. The CRf group had a decreased left atrial active emptying fraction (0.25 +/- 0.08) compared with the CR (0.36 +/- 0.09) and N groups (0.39 +/- 0.08), p < 0.001 for both comparisons. The reservoir fraction was decreased only in the CRf group compared to normal subjects (1.37 +/- 0.25 vs. 1.82 +/- 0.43, p < 0.001).
CONCLUSIONS: These results suggest that the occurrence of paroxysmal atrial fibrillation in patients with a high CRP level is associated with enlargement of the left atrium, depression of its contractile function and is independent of left ventricular hypertrophy and function. The mechanisms linking these variables remain undefined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117749     DOI: 10.2143/AC.61.5.2017764

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  6 in total

1.  Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset.

Authors:  Pier Luigi Pellegrino; Natale Daniele Brunetti; Luisa De Gennaro; Luigi Ziccardi; Massimo Grimaldi; Matteo Di Biase
Journal:  Intern Emerg Med       Date:  2011-03-30       Impact factor: 3.397

2.  C-Reactive Protein and High-Sensitive Cardiac Troponins Correlate with Oxidative Stress in Valvular Heart Disease Patients.

Authors:  Muhammad Ishtiaq Jan; Riaz Anwar Khan; Ijaz Ahmad; Naeem Khan; Komal Urooj; Azhar Ul Haq Ali Shah; Asif Ullah Khan; Tahir Ali; Ayesha Ishtiaq; Muhib Shah; Anwar Ullah; Iram Murtaza; Riaz Ullah; Amal Alotaibi; H C Ananda Murthy
Journal:  Oxid Med Cell Longev       Date:  2022-04-30       Impact factor: 7.310

Review 3.  Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation.

Authors:  Mario Piergiulio Pezzo; Antonella Tufano; Massimo Franchini
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

Review 4.  A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.

Authors:  Luxiang Shang; Ling Zhang; Yankai Guo; Huaxin Sun; Xiaoxue Zhang; Yakun Bo; Xianhui Zhou; Baopeng Tang
Journal:  Front Cardiovasc Med       Date:  2021-07-01

5.  Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation.

Authors:  Noboru Ichihara; Masatoshi Miyamura; Daichi Maeda; Tomohiro Fujisaka; Shu-Ichi Fujita; Hideaki Morita; Yoshihiro Takeda; Takahide Ito; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  J Arrhythm       Date:  2017-05-30

Review 6.  Characterization, Pathogenesis, and Clinical Implications of Inflammation-Related Atrial Myopathy as an Important Cause of Atrial Fibrillation.

Authors:  Milton Packer
Journal:  J Am Heart Assoc       Date:  2020-04-03       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.